SHPH

Shuttle Pharmaceuticals Holdings, Inc. (SHPH) Risks & Opportunities Analysis (2026)

Invetso Score: 6.1/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Risks

Score: 5.8 (Moderate)

Current liquidity is very weak versus most peers, with a 0.30 current ratio, so any working-capital shock could constrain growth financing and supplier terms.

Negative interest coverage and minimal net debt indicate earnings quality is not yet supporting obligations, leaving SHPH more exposed than better-capitalized peers if funding conditions tighten.

An extreme cash conversion cycle driven by very long payables suggests dependence on supplier financing, which can reverse faster than in peers and pressure operations.

The absence of reported FCF margin limits visibility on self-funding capacity, so SHPH appears less resilient than peers with clearer cash generation in a slower demand environment.

Opportunities

Score:

Very low leverage versus peers provides balance-sheet flexibility, so SHPH can absorb volatility or fund selective growth more easily than highly levered competitors.

Negative working-capital dynamics can support cash preservation when managed well, giving SHPH a potential liquidity advantage over peers that must fund inventory and receivables.

If operating performance improves, the low debt load should allow faster earnings-to-cash conversion than peers, amplifying upside from even modest margin recovery.

The current capital structure leaves room to pursue strategic actions or refinancing on better terms than more indebted peers, improving positioning if market conditions stabilize.

Overall Score

Score:

SHPH’s low leverage and potential cash-preservation benefits are offset by very weak liquidity, negative coverage, and limited cash-flow visibility versus peers.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Shuttle Pharmaceuticals Holdings, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →